Biotech · Private company
PharmaBio Development Inc.
Track this companyFree. Adds PharmaBio Development Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal CancerPHASE1_PHASE2 · TERMINATED · started Sep 30, 2011ClinicalTrials.gov NCT01347645 · fetched Nov 12, 2026
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and NeckPHASE1_PHASE2 · COMPLETED · started Sep 19, 2011ClinicalTrials.gov NCT01332266 · fetched Nov 12, 2026
- E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular CarcinomaPHASE1_PHASE2 · COMPLETED · started Jul 19, 2011ClinicalTrials.gov NCT01271504 · fetched Nov 12, 2026
- Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV MelanomaPHASE2 · COMPLETED · started Jun 22, 2010ClinicalTrials.gov NCT01127451 · fetched Nov 12, 2026
- Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder CancerPHASE1_PHASE2 · TERMINATED · started Apr 16, 2010ClinicalTrials.gov NCT01126749 · fetched Nov 12, 2026
- E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125PHASE1_PHASE2 · TERMINATED · started Mar 1, 2010ClinicalTrials.gov NCT01133756 · fetched Nov 12, 2026